Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keppra Monotherapy Conversion in Partial Epilepsy
NCT00630357Phase 4Completed
- Sponsor
- UCB
- Start
- Mar 2003
- Primary completion
- Jul 2004
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of levetiracetam in epilepsy, sponsored by UCB. Primary endpoint: Seizure Freedom with Keppra Flexible Dose. Started Mar 2003; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00630357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630357.